善宁

  • 网络Sandostatin;Octreotide
善宁善宁
  1. 善宁组大鼠对SAP大鼠血清淀粉酶水平及胰腺病理评分明显改善、SOD及MDA等各指标无明显变化。

    Sandostatin rats to SAP serum amylase level and pancreas pathological score significantly improve , SOD and MDA and so on various index no change .

  2. 善宁区域性动脉灌注治疗重症急性胰腺炎

    Local arterial infusion of sandostatin for treating severe acute pancreatitis

  3. 善宁对十二指肠溃疡出血者胃内pH的影响

    Effect of octreotide on intragastric pH in patients with duodenal ulcer bleeding

  4. 食管静脉曲张破裂出血患者善宁治疗前血清ACE浓度明显高于治疗72小时后的水平。

    The serum ACE level in patients with liver cirrhosis before treatment was significantly higher than that 72 hours after treatment .

  5. 方法:采用紫外光度比色分析法测定40例肝硬化食管静脉曲张破裂出血患者善宁治疗前、后及20例健康对照者血清ACE浓度。

    METHODS : Serum ACE was measured by UV - spectrocolorimetry in 40 cases of liver cirrhosis with esophageal varices hemorrhage before and after sandostatin therapy and 20 healthy controls .

  6. 结果:应用三七皂甙和善宁后大鼠腹水减少、病理改变减轻,血清淀粉酶、TNFα和TXB2均明显降低(P<0.05);

    Results : The ascites , the pathological changes in the pancreas and the lung , the serum amylase , TNF α and TXB 2 in the group of using PNGS and in the group of using somatostatin group obviously decreased ( P < 0.05 ) .

  7. 善宁2组(静注0.1mg,后42μg/h连续恒速静滴);

    The patients in group 2 received an intravenous injection of 0.1 mg of octreotide followed by continuous intravenous drip of octreotide at a constant speed of 42 μ g / h for 24 hours .

  8. 目的:评价善宁对大咯血抢救的疗效。

    Objective : To evaluate the efficacy of Sandostatin in salvaging heavy hemoptysis .

  9. 目的总结在常规治疗无效的各型顽固性腹泻使用善宁治疗的疗效。

    Objective : To summarize the therapeutic effect of somatostatin on intractable diarrhea .

  10. 实验组术后发生胰瘘3例,常规应用善宁治疗,无死亡病例。

    Pancreatic fistula occurred in 3 cases in sandostatin group , no death occurred .

  11. 可利新、思他宁和善宁治疗肝硬化食管静脉曲张破裂出血的费用-效果分析

    The Analysis of Cost-Effectiveness of Controlling Esophageal Variceal Bleeding of Glypressin , Somatostatin and Octreotide

  12. 对照组予善德定(善宁)或施他宁加抗生素及基础性支持治疗。

    The control group was treated with Octreotide Acetate Injection Shitaining and Antibiotic plus base treatment .

  13. 结论:应用施他宁相对低廉,成本-效果比优于善宁。两组的不良反应无显著性差异。

    CONCLUSION : Somatostatin is cheaper in cost and better in cost - effective ratio in comparison with Octreotide .

  14. 目的探讨善宁治疗常规治疗无效的严重化疗相关性腹泻的疗效。

    Objective To summarize the therapeutic effect of Sandostain on chemotherapy-induced diarrhea which couldn tbe cured with routine therapy .

  15. 结论:善宁能有效降低重症胰腺炎患者的血清淀粉酶含量有明显疗效。

    Conclusions : Octreotide can decrease greatly the levels of serum amylase , exhibiting obvious therapeutic effects on severe acute pancreatitis .

  16. 联合组d14CD4阳性细胞百分比、CD4/CD8值高于单用善宁组和对照组(P<0.05)。

    CD4 positive cell and CD4 / CD8 ratio of CT group were higher than those of ST and control groups on d14 ( P < 0.05 ) .

  17. 方法:将72例肝硬化门脉高压食管胃底静脉出血患者分为善宁组和垂体后叶素组,进行临床疗效的对比观察。

    Methods 72 patients suffered from bleeding in gastro-esophageal varices for cirrhosis were divided into two groups , and clinical effect of Sandostatin and Vasopressin were measured respectively .

  18. 目的观察结肠癌患者术前麻醉诱导期联合应用善宁、卡铂对结肠淋巴结铂浓度的影响,以及预防性腹腔内淋巴化疗对术后腹膜后淋巴结转移的影响。

    Abstracts [ WT5BZ ] To evaluate the effect of intraperitoneal lymphatic chemotherapy with carboplatin and sandostatin on colonic carcinoma and abdominal lymphatic metastasis in patients after radical resection .

  19. 结论:国产注射用醋酸奥曲肽用于治疗食管胃底静脉曲张破裂出血安全、有效,与同剂量善宁!醋酸奥曲肽治疗食道胃底静脉曲张破裂出血18例分析

    Conclusions : Domestic-made octreotide acetate injection is effective and safe in the treatment of esophagogastric variceal bleeding . Analysis of Clinical Cases of Gastroesophageal Variceal Bleeding Using Octreotide Acetate in 18 Patients

  20. 胰炎合剂组及善宁组细胞凋亡率及凋亡基因表达量明显高于其他两组(P<0.05或P<0.01)。

    The apoptosis rate and the expressive quantity of Bax / bcl-2 in ' Pancreatitis Mixture ' and Sandostatin groups were higher than those in the other two groups ( P < 0.05 , P < 0.01 ) .

  21. 目的观察肝缺血再灌注和缺血预处理后ERK1/2活化的情况,以探讨其在肝脏缺血再灌注损伤和缺血预处理保护中的作用。善宁对大鼠肝缺血再灌注模型的保护作用(英文)

    [ Objective ] To Study activation of ERK1 / 2 in hepatic ischemia-reperfusion and hepatic ischemic preconditioning settings , and its role in hepatic ischemia-reperfusion injury and protection in hepatic preconditioning . [ Methods ] The orthotopic partial hepatic ischemia / reperfusion animal model was used .